Intellia Therapeutics Inc sell StockNews.com
Start price
08.11.25
/
50%
€9.06
Target price
08.11.26
-
Performance (%)
22.90%
Price
24.03.26
€11.13
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 22.90%. This prediction currently runs until 08.11.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -4.872% | -4.872% |
| iShares Core DAX® | -3,51 % | -8,75 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % |
| iShares S&P 500 | -2,60 % | -2,23 % |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
18.01.26
18.01.26
-
18.01.27
18.01.27
5.00%
24.03.26
24.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.90
27.12.25
27.12.25
-
27.12.26
27.12.26
40.85%
24.03.26
24.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.77
30.11.25
30.11.25
-
30.11.26
30.11.26
43.28%
24.03.26
24.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.51
11.05.24
11.05.24
-
11.05.25
11.05.25
-67.08%
12.05.25
12.05.25